Previous close | 27.52 |
Open | 26.93 |
Bid | 26.87 x 700 |
Ask | 26.91 x 200 |
Day's range | 26.30 - 27.14 |
52-week range | 26.30 - 63.57 |
Volume | |
Avg. volume | 1,433,903 |
Market cap | 3.206B |
Beta (5Y monthly) | 1.89 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.18 |
Earnings date | 30 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 53.57 |
In this piece, we will take a look at the 11 oversold midcap stocks to buy now. If you want to skip our coverage of overbought, oversold, small cap, and mid cap stocks along with the latest stock market news, then you can skip ahead to the 5 Oversold MidCap Stocks To Buy Now. Since […]
10x Genomics (TXG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
10x Genomics (TXG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.